Course Information
45th Annual UCLA State-of-the-Art Urology Conference

The Ritz-Carlton
Marina del Rey, California
March 06, 2020 to March 08, 2020
*Please note that the course syllabus will be available online only to registered attendees.
A password link will be sent prior to the course.

Download: [ PDF ]

Course Description

This course explores the most challenging management problems facing the practicing urologist. Distinguished faculty present current information and techniques in urologic oncology (prostate, bladder, kidney), male and female voiding dysfunction and incontinence, pelvic prolapse, the latest BPH technologies, renal and ureteral stones, testosterone replacement therapy, shock wave therapy for erectile dysfunction, Peyronie’s disease, imaging (fluciclovine scan and PSMA PET), ablative therapies, genetic testing, robotic and endoscopic surgery, BCG unresponsive bladder cancer, management of the small renal mass and Bosniak cysts, avoidance and management of malpractice claims, practice management and coding, and pediatric urology. The conference emphasizes interaction between participants and faculty and allows ample time for case presentations and group discussions, ensuring an outstanding educational experience for attendees.

Registration Information


To enroll click here.


By Mail

Send the completed enrollment form to:

David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
Urology Conference
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512

By Fax

Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.

By Phone

Use your American Express, MasterCard, VISA, or Discover card. Call (310) 794-2620

Course Fees

(Fees include course registration and materials, daily continental breakfasts and breaks, Friday evening reception, and Friday and Saturday luncheons.)

  • $550.00 Physicians
  • $350.00 David Geffen School of Medicine at UCLA Faculty*
  • $275.00 Non-Physician, Healthcare Professionals
  • $110.00 Residents (accompanied by a confirmatory letter of status from department chief or training director)

*Please indicate faculty appointment title and campus on registration form.


Cancellations must be received in writing by January 31, 2020, and will be subject to a $75 processing fee. No refunds will be given after that date. If, for any reason, the course must be canceled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided. You may fax your refund request to 310-794-2624.


Course Chair Course Co-Chairs

William J. Aronson, MD

Craig Canfield, MD

Karim Chamie, MD, MSHS

Guest Faculty

Benjamin M. Brucker, MD 
Associate Professor 
Director of FPMRS and Neurourology at NYU Langone Health
Department of Urology and Obstetrics & Gynecology
New York, New York 

June M. Chan, ScD
Professor, Epidemiology & Biostatistics and Urology
San Francisco, California

Anthony V. D’Amico, MD, PhD
Eleanor Teresa Walters Chair of Genitourinary Radiation Oncology at Brigham and Women’s Hospital
Professor of Radiation Oncology
Brigham and Women’s Hospital
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

Neil E. Fleshner, MD, MPH, FRCSC
Professor of Surgery and Martin Barkin Chair of Urology 
University of Toronto 
Division of Urology, University Health Network Love Chair in Prostate Cancer Prevention
Princess Margaret Cancer Centre
Toronto, Ontario 

Mohit Khera, MD, MBA, MPH
Professor of Urology 
Director, Laboratory for Andrology Research 
Baylor College of Medicine
Scott Department of Urology 
Houston, Texas

James E. Lingeman, MD
Department of Urology
Indiana University School of Medicine
Indianapolis, Indiana

Mark N. Painter, BA, CPMA
Denver, Colorado

Jaspreet S. Sandhu, MD
Associate Attending Urologist, Department of Surgery, Urology Service
Memorial Sloan Kettering Cancer Center
Associate Professor, Department of Urology
Weill Cornell Medical College
New York, New York

Eila C. Skinner, MD 
Thomas A. Stamey Research Professor of Urology
Chair, Department of Urology
Stanford University School of Medicine
Palo Alto, California 

Nicholas J. Vogelzang, MD, FACP, FASCO
Clinical Professor of Medicine, University of Nevada Las Vegas
US Oncology Research
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada

Department of Urology Faculty*

Mark S. Litwin, MD, MPH
Professor and Chair
Department of Urology
Professor of Health Policy and Management
School of Public Health

William J. Aronson, MD

Z. Chad Baxter, MD

Karim Chamie, MD, MSHS

Arnold I. Chin, MD, PhD

Matthew Dunn, MD

Ja-Hong Kim, MD

Steven E. Lerman, MD

Leonard S. Marks, MD

Jesse N. Mills, MD

Victor W. Nitti, MD

Allan J. Pantuck, MD, MS

Nishant D. Patel, MD 

Jacob Rajfer, MD

Brian Shuch, MD

Jennifer S. Singer, MD

Robert E. Reiter, MD, MBA

Christopher S. Saigal, MD, MPH

Renea Sturm, MD

UCLA Faculty

Alexandra Drakaki, MD, PhD
Assistant Professor of Medicine and Urology
Director - Genitourinary Medical Oncology Program
Co-Director of Research, GU Trials Program
Division of Hematology/Oncology and Institute of Urologic Oncology

Amar U. Kishan, MD 
Assistant Professor 
Department of Radiation Oncology
Professor of Radiology, Surgery and Urology
Department of Radiology

Johanna Klohn, MPH, Esq.
Chief Risk Officer
UCLA Health

Sandy T. Liu, MD
Division of Hematology-Oncology, Department of Medicine 
Institute of Urologic Oncology, Department of Urology

Steven S. Raman, MD
Professor of Radiology, Surgery and Urology
Department of Radiology

*David Geffen School of Medicine at UCLA

Program Agenda

Friday, March 6, 2020


Registration / Breakfast / Exhibits


Introduction and Announcements
William J. Aronson, MD

Male and Female Voiding Dysfunction, Reconstruction
Moderator: Victor W. Nitti, MD


Pelvic Organ Prolapse: What Every Urologist Needs to Know
Victor W. Nitti, MD


Stress Urinary Incontinence in 2020 – Shared Decision Making
Benjamin M. Brucker, MD


Female Urethral Stricture – A Real Entity: Diagnosis and Management
Victor W. Nitti, MD


Panel – Management of SUI Surgery Complications
Moderator: Dr. Kim
Panel: Drs. Baxter, Brucker, Nitti, and Sandhu


Break / Exhibits


Optimizing Surgical Management of Male Incontinence
Jaspreet S. Sandhu, MD


Neurourology Updates: The Lessons I Have Learned From My Patients
Benjamin M. Brucker, MD


Minimally Invasive Treatments of the Moderately Enlarged Prostate - Which Procedure to Choose
Jaspreet S. Sandhu, MD


Point Counterpoint – Surgical Intervention for the Large Prostate (>150cc)
Robotic Simple
Benjamin M. Brucker, MD
James E. Lingeman, MD


Panel: Complex Cases in Male Lower Urinary Tract Dysfunction
Moderator: Dr. Victor W. Nitti
Panel: Drs. Baxter, Brucker, Kim, Lingeman, and Sandhu



Moderator: Matthew Dunn, MD


Endoscopic Management of Ureteral Strictures
Matthew Dunn, MD


Optimizing ESWL Outcomes and the Next Generation Technology
James E. Lingeman, MD


Optimizing Pain Management and Avoiding Opioid Addiction in Patients with Stones
Nishant D. Patel, MD


Operative Stone
Strategies Tips and Tricks
James E. Lingeman, MD


Panel Discussion and Case Presentations
Moderator: Dr. Matthew Dunn
Panel: Drs. Lingeman and Patel


Break / Exhibits

Men’s Health – Testosterone Replacement, Erectile Dysfunction, Peyronie’s, Exercise
Moderator: Jacob Rajfer, MD


Guidelines in 2020 for TRT
Counseling Patients About Side Effects
New Formulations – SubQ and IM
Mohit Khera, MD, MBA, MPH


Optimizing Collagenase Treatment for Peyronie’s Disease
Management of Complications
Jesse N. Mills, MD


Shock Wave Therapy and Stem Cells for Erectile Dysfunction
What Are the Facts
Mohit Khera, MD, MBA, MPH


Exercise and Prostate Cancer
New Data and Guidelines
Tips and Tools For Your Patients
June M. Chan, ScD


Panel Discussion and Case Presentations
Moderator: Dr. Jacob Rajfer
Panel: Drs. Chan, Khera, and Mills


Adjourn and Reception


Saturday, March 7, 2020


Breakfast / Exhibits


Robotic Radical Prostatectomy
Optimizing Outcomes
Continence, Potency, Advanced Disease
Robert E. Reiter, MD, MBA

Prostate Cancer
Moderator: Mark S. Litwin, MD, MPH


Adjuvant vs. Salvage RT – New Findings and Recommendations
Anthony V. D’Amico, MD, PhD


Present and New Biomarkers for Screening
Neil E. Fleshner, MD, MPH, FRCSC


Debate – Focal Therapy for Intermediate Risk Disease
Pro – Leonard S. Marks, MD
Con – Robert E. Reiter, MD, MBA


The ABC’s of Genetic Testing at Diagnosis – Who Needs It, How to Do It, How to Interpret, Counseling and Treatment Implications
Neil E. Fleshner, MD, MPH, FRCSC


Use of MRI-Guided Biopsy in Active Surveillance
Leonard S. Marks, MD


Panel Discussion and Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Marks, D’Amico, Fleshner, Marks, Reiter, and Vogelzang


Break / Exhibits


Imaging of Prostate Cancer in 2020: Fluciclovine and PSMA
Robert E. Reiter, MD, MBA


Management of Advanced and Oligometastatic Disease
Anthony V. D’Amico, MD, PhD


Sequencing Treatment and Emerging Therapies – State of the Art in 2020
Nicholas J. Vogelzang, MD, FACP, FASCO


Panel Discussion and Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Marks, D’Amico, Fleshner, Marks, Reiter, and Vogelzang



Bladder Cancer
Moderator: Mark S. Litwin, MD, MPH


New Advances in Bladder Cancer in 2020
Nicholas J. Vogelzang, MD, FACP, FASCO


Risk-Adapted Treatment of NMIBC
Eila C. Skinner, MD


Upper Tract Urothelial Cancer
Karim Chamie, MD, MSHS


BCG Unresponsive Urothelial Cancer –Management Strategies
Eila C. Skinner, MD


Panel Discussion and Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Chamie, Chin, Drakaki, Kishan, Skinner, and Vogelzang


Break / Exhibits

Kidney Cancer, Cancer Care Economics
Moderator: Brian Shuch, MD


Cancer Care Economics
Christopher S. Saigal, MD, MPH


Active Surveillance Strategies for the Small Renal Mass – State of the Art
Brian Shuch, MD


Key Developments in Advanced Kidney Cancer
Nicholas J. Vogelzang, MD, FACP, FASCO


Management of Bosniak Cysts
Role of Biopsy and Observation
Brian Shuch, MD


Panel Discussion and Case Presentations
• Who Needs Genetics Testing
• Bilateral Small Renal Tumors
• Partial vs Radical Nephrectomy
• Imaging in the Setting of Renal Dysfunction
• Importance of Pathology Subtypes
Moderator: Dr. Brian Shuch
Panel: Drs. Chamie, Liu, Pantuck, Raman, Saigal, and Vogelzang




Sunday, March 8, 2020


Breakfast / Exhibits


Endourology Tips and Tricks
HOLEP – Surgical Technique
Matthew Dunn, MD

Practice Management
Moderator: Christopher S. Saigal, MD, MPH


Practice Management
• E/M Coding – Preparing for 2021 Changes
• RVUs – Practical Applications for Urology Employment and Practice Analysis
• Telemedicine – 2019 Changes for Medicare Advantage Plans
• Surgical Case Coding
• Modifiers – How and When to Use Them
• New Technology – Financial Impact and Implementation
• Surviving MIPS/MACRA
Mark N. Painter, BA, CPMA


Break / Exhibits

Medical Malpractice
Moderator: William J. Aronson, MD


Avoiding and Surviving Medical Malpractice Claims
Johanna Klohn, MPH, Esq

Pediatric Urology
Moderator: Steven E. Lerman, MD


What’s New in Pediatric Urology
Steven E. Lerman, MD


Pediatric Urology Panel Discussion and Case Presentations
Moderator: Dr. Steven E. Lerman
Panel: Drs. Singer and Sturm




At the completion of this program, participants should be better able to:

  • Utilize MRI for prostate cancer detection and active surveillance
  • Utilize molecular markers for prostate cancer screening
  • Counsel patients on focal therapy for prostate cancer
  • Understand the present role for fluciclovine and PSMA imaging
  • Utilize germline and somatic genetic testing for patients with prostate cancer
  • Manage patients with BCG unresponsive bladder cancer
  • Manage patients with upper tract urothelial cancer
  • Manage small renal masses and Bosniak cysts
  • Understand the role of the latest BPH technologies
  • Prescribe exercise regimens for prostate cancer patients
  • Manage male and female voiding dysfunction
  • Manage patients with neurogenic bladder
  • Manage patients with kidney and ureteral stones
  • Avoid opioid addiction in patients with stones
  • Counsel and treat patients with testosterone deficiency
  • Understand the role for shock wave and stem cell therapy for ED
  • Optimize collagenase treatment for patients with Peyronie’s
  • Navigate coding and related practice management issues
  • Sequence therapy for advanced prostate cancer
  • Avoid and navigate malpractice claims

A few days before the meeting you will be emailed a link and a password to download the individual speaker handouts.


The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 22.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies. 

American Society of Radiologic Technologists Credit 

Approved by the ASRT for a maximum of 14.25 Category A continuing education credits.


The FDA has issued a concept paper that classifies the commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. Along with independence, the FDA requires that non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the sponsor adequately manage all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts. 

The Department of Urology is a California Board of Nursing approved provider (#8888).



The Ritz-Carlton, Marina del Rey
4375 Admiralty Way
Marina del Rey, California 90292
310-823-1700 or 800-241-3333
310-823-2404 facsimile

Transportation, Accommodations, and Parking

Taxi or shuttle service is available from Los Angeles International Airport to the Ritz-Carlton, Marina del Rey.

A block of rooms has been reserved at the Ritz-Carlton for conference participants at a special conference rate of $319 plus tax per night for single/double occupancy. One night’s deposit is required to guarantee late arrival (after 5 pm). Confirmation of reservations received after February 4, 2020 is subject to availability. For reservations call 310-823-1700 or 800-241-3333. Be sure to mention UCLA's State-of-the-Art Urology Conference when calling in your reservations. You may also visit their website.

Daytime: $14 valet only
Overnight: $30